Effects of splicing-regulatory polymorphisms in ABCC2, ABCG2, and ABCB1 on methotrexate exposure in Chinese children with acute lymphoblastic leukemia

被引:0
|
作者
Miao Li
Xiao-Yan Kong
Shu-Mei Wang
机构
[1] Beijing Shijitan Hospital,Department of Pediatrics
[2] Capital Medical University,Department of Pharmacy
[3] Armed Police Beijing Corps Hospital,Department of Pharmacy
[4] Beijing Shijitan Hospital,undefined
[5] Capital Medical University,undefined
[6] Beijing Key Laboratory of Bio-Characteristic Profiling for Evaluation of Rational Drug Use,undefined
[7] International Cooperation and Joint Laboratory of Bio-Characteristic Profiling for Evaluation of Rational Drug Use,undefined
来源
关键词
Acute lymphoblastic leukemia; Methotrexate; ABC transporter; Single-nucleotide polymorphism; Alternative splicing;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:77 / 87
页数:10
相关论文
共 50 条
  • [1] Effects of splicing-regulatory polymorphisms in ABCC2, ABCG2, and ABCB1 on methotrexate exposure in Chinese children with acute lymphoblastic leukemia
    Li, Miao
    Kong, Xiao-Yan
    Wang, Shu-Mei
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 91 (01) : 77 - 87
  • [2] Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo
    Colombo, S
    Soranzo, N
    Rotger, M
    Sprenger, R
    Bleiber, G
    Furrer, H
    Buclin, T
    Goldstein, D
    Décosterd, L
    Telenti, A
    [J]. PHARMACOGENETICS AND GENOMICS, 2005, 15 (09): : 599 - 608
  • [3] Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib
    Loscocco, Federica
    Visani, Giuseppe
    Ruzzo, Annamaria
    Bagaloni, Irene
    Fuligni, Fabio
    Galimberti, Sara
    Di Paolo, Antonello
    Stagno, Fabio
    Pregno, Patrizia
    Annunziata, Mario
    Gozzini, Antonella
    Barulli, Sara
    Gabucci, Elisa
    Magnani, Mauro
    Isidori, Alessandro
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis
    Campa, Daniele
    Mueller, Phillip
    Edler, Lutz
    Knoefel, Lena
    Barale, Roberto
    Heussel, Claus P.
    Thomas, Michael
    Canzian, Federico
    Risch, Angela
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (12) : 2920 - 2928
  • [5] LACK OF ASSOCIATION BETWEEN ABCB1, ABCG2, AND ABCC2 GENETIC POLYMORPHISMS AND MULTIDRUG RESISTANCE IN EPILEPSY
    Kim, D.
    Lee, S.
    Chu, K.
    [J]. EPILEPSIA, 2009, 50 : 124 - 124
  • [6] Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance
    Bruhn, Oliver
    Cascorbi, Ingolf
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (10) : 1337 - 1354
  • [7] Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy
    Kim, Dong Wook
    Lee, Sang Kun
    Chu, Kon
    Jang, In-Jin
    Yu, Kyung-Sang
    Cho, Joo-Youn
    Kim, Seon-Jeong
    [J]. EPILEPSY RESEARCH, 2009, 84 (01) : 86 - 90
  • [8] Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine
    Neumanova, Zuzana
    Cerveny, Lukas
    Ceckova, Martina
    Staud, Frantisek
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 2016, 37 (01) : 28 - 38
  • [9] A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk
    Campa, Daniele
    Butterbach, Katja
    Slager, Susan L.
    Skibola, Christine F.
    de Sanjose, Silvia
    Benavente, Yolanda
    Becker, Nikolaus
    Foretova, Lenka
    Maynadie, Marc
    Cocco, Pierluigi
    Staines, Anthony
    Kaaks, Rudolf
    Boffetta, Paolo
    Brennan, Paul
    Conde, Lucia
    Bracci, Paige M.
    Caporaso, Neil E.
    Strom, Sara S.
    Camp, Nicola J.
    Cerhan, James R.
    Canzian, Federico
    Nieters, Alexandra
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (04) : 803 - 812
  • [10] Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib
    Akimitsu Maeda
    Hitoshi Ando
    Kei Irie
    Naoya Hashimoto
    Jun-ichi Morishige
    Shoji Fukushima
    Akira Okada
    Hiromichi Ebi
    Masahide Matsuzaki
    Hiroji Iwata
    Masataka Sawaki
    [J]. European Journal of Clinical Pharmacology, 2022, 78 : 1239 - 1247